Alisa S. W. Shum
- Development of drugs for prevention and treatment of metabesity (obesity, type 2 diabetes and related metabolic disorders) and neurodegenerative diseases
- Mechanisms underlying fetal programming of obesity, diabetes, hypertension and neurologic disorders
- In utero therapeutic interventions to combat against the adverse effects of maternal diabetes and obesity on embryo development
- Mechanisms underlying abnormal development of the central nervous system